SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-100127
Filing Date
2016-05-10
Accepted
2016-05-10 08:00:31
Documents
18
Period of Report
2016-05-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v439253_8k.htm 8-K 13748
2 EXHIBIT 99.1 v439253_ex99-1.htm EX-99.1 12221
3 GRAPHIC image_001.jpg GRAPHIC 5687
4 GRAPHIC ex99x1_001.jpg GRAPHIC 120569
5 GRAPHIC ex99x1_002.jpg GRAPHIC 93845
6 GRAPHIC ex99x1_003.jpg GRAPHIC 105125
7 GRAPHIC ex99x1_004.jpg GRAPHIC 71786
8 GRAPHIC ex99x1_005.jpg GRAPHIC 57005
9 GRAPHIC ex99x1_006.jpg GRAPHIC 60853
10 GRAPHIC ex99x1_007.jpg GRAPHIC 66332
11 GRAPHIC ex99x1_008.jpg GRAPHIC 89410
12 GRAPHIC ex99x1_009.jpg GRAPHIC 64539
13 GRAPHIC ex99x1_010.jpg GRAPHIC 53682
14 GRAPHIC ex99x1_011.jpg GRAPHIC 72935
15 GRAPHIC ex99x1_012.jpg GRAPHIC 62310
16 GRAPHIC ex99x1_013.jpg GRAPHIC 82607
17 GRAPHIC ex99x1_014.jpg GRAPHIC 75089
18 GRAPHIC ex99x1_015.jpg GRAPHIC 65939
  Complete submission text file 0001144204-16-100127.txt   1609576
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 161633743
SIC: 2834 Pharmaceutical Preparations